Business

AstraZeneca and Oxford defend Covid vaccine trials after questions raised in the U.S. | CNBC

Read more at www.cnbc.com

“We believe that this product will never be licensed in the U.S.,” one group of critical U.S.-based analysts wrote this week.
Tags
Back to top button
error: